Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
2.050
-0.105 (-4.87%)
Nov 20, 2026, 4:08 PM HKT
| Market Cap | 5.82B -25.3% |
| Revenue (ttm) | 777.26M -6.6% |
| Net Income | -120.60M |
| EPS | -0.10 |
| Shares Out | 1.04B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,564,000 |
| Open | 2.130 |
| Previous Close | 2.155 |
| Day's Range | 2.030 - 2.145 |
| 52-Week Range | 2.035 - 3.690 |
| Beta | 0.10 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |